Market Place
Sourcing Support
All News #Library
Others
Verismo Secures $28M from HLB to Accelerate KIR-CAR Trial
15 Apr 2026 //
FIRSTWORD PHARMA
Verismo Wins Best Workplace in Philadelphia for Third Year
29 Jul 2025 //
PR NEWSWIRE
Verismo Therapeutics Announces Upcoming Presentation at SITC 2023
03 Nov 2023 //
PR NEWSWIRE
Verismo starts patient enrolment for STAR-101 Phase I trial
03 May 2023 //
CLINICAL TRIALS ARENA
US FDA grants orphan drug status for Verismo’s mesothelioma therapy
29 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
FDA grants IND clearance for Verismo’s cancer therapy trial
21 Sep 2022 //
CLINICALTRIALSARENA
Verismo Announces FDA Clearance of IND Application for SynKIR-110
20 Sep 2022 //
FIRSTWORLDPHARMA
Verismo Therapeutics Announces FDA Clearance of IND Application for SynKIR-110
20 Sep 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.